N/A
N=22
Mobile Technology for Reducing and Preventing Adolescent Suicide
Suicide, Attempted · Suicidal Ideation
Bottom Line
View on ClinicalTrials.gov: NCT04896593 ↗Enrolled (actual)
22
Serious AEs
40.9%
Results posted
Mar 2023
Primary outcome: Primary: App Usability 1 Week — 83.948 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Smartphone App (Behavioral)
- Age
- Pediatric · 13+ yrs
- Sex
- All
- Sponsor
- Hartford Hospital
- Primary completion
- May 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY App Usability 1 Week |
83.948 | — |
| PRIMARY App Usability 4 Weeks |
86.875 | — |
| PRIMARY App Usability 8 Weeks |
85.500 | — |
| PRIMARY App Usability 12 Weeks |
86.833 | — |
| PRIMARY App Usability 16 Weeks |
85.625 | — |
| SECONDARY Suicidal Ideation Baseline |
54.700 | — |
| SECONDARY Suicidal Ideation 1 Week |
43.421 | — |
| SECONDARY Suicidal Ideation 4 Weeks |
27.125 | — |
| SECONDARY Suicidal Ideation 8 Weeks |
25.200 | — |
| SECONDARY Suicidal Ideation 12 Weeks |
26.867 | — |
| SECONDARY Suicidal Ideation 16 Weeks |
26.625 | — |
Summary
This single-group open-label trial will evaluate the feasibility and preliminary efficacy of a suicide prevention mobile application when used as an adjunct to usual care in adolescents.
Eligibility Criteria
Inclusion Criteria
- Inpatient psychiatric patients who have attempted suicide (lifetime) or have documented suicide ideation and a plan to harm themselves at admission
- Understand written and spoken English
- Own an iPhone with iOS 11 or higher, or Android with OS 8.1 or higher
- Willing and able to complete enrollment procedures
- Parent/guardian (and youth) able to understand the nature of the study and provide written informed consent (assent for youth)
- Willing to agree to release of information to their parent/guardian and providers when clinically indicated.
- Discharge plan includes aftercare within the Hartford HealthCare system (to facilitate coordination of care during follow up)
Exclusion Criteria
- Patients with active psychosis
- Patients experiencing substance withdrawal
- Currently enrolled in other treatment studies for the symptoms and behaviors targeted
- Patient unwilling or unable to wear mask during in-person study procedures
- Patients who, in the judgment of the investigator, would have an unfavorable risk/benefit profile with respect to the Smartphone App.
- Any other psychiatric or medical condition (e.g., intellectual disability) or custody arrangement that in the investigator's opinion would preclude informed consent/assent or participation in the trial.
Data sourced from ClinicalTrials.gov (NCT04896593). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.